​

Insulet (PODD) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

PODD Stock Forecast

Insulet (PODD) stock forecast, based on 46 Wall Street analysts, predicts a 12-month average price target of $378.90, with a high of $450.00 and a low of $274.00. This represents a 39.66% increase from the last price of $271.31.

$150 $210 $270 $330 $390 $450 High: $450 Avg: $378.9 Low: $274 Last Closed Price: $271.31

PODD Stock Rating

Insulet stock's rating consensus is Buy, based on 46 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 32 Buy (69.57%), 11 Hold (23.91%), 3 Sell (6.52%), and 0 Strong Sell (0.00%).

Buy
Total 46 0 3 11 32 Strong Sell Sell Hold Buy Strong Buy

PODD Price Target Upside V Benchmarks

TypeNameUpside
StockInsulet39.66%
SectorHealthcare Stocks 15.45%
IndustryMedical Device Stocks19.94%

Price Target Trends

1M3M12M
# Anlaysts31417
Avg Price Target$339.67$378.86$375.88
Last Closing Price$271.31$271.31$271.31
Upside/Downside25.20%39.64%38.54%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jan, 265192--26
Dec, 255182--25
Nov, 255173--25
Oct, 255163--24
Sep, 255163--24
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jan 12, 2026Barclays$274.00$286.92-4.50%0.99%
Jan 09, 2026Lee HambrightBernstein$380.00$292.8929.74%40.06%
Jan 09, 2026David RomanGoldman Sachs$365.00$292.8924.62%34.53%
Dec 18, 2025Truist Financial$390.00$296.4231.57%43.75%
Dec 17, 2025Canaccord Genuity$450.00$288.7355.85%65.86%
Dec 16, 2025Evercore ISI$370.00$295.3125.29%36.38%
Nov 24, 2025Canaccord Genuity$432.00$331.1730.45%59.23%
Nov 21, 2025Richard NewitterTruist Financial$412.00$325.0026.77%51.86%
Nov 21, 2025Shagun SinghRBC Capital$380.00$324.2017.21%40.06%
Nov 21, 2025BTIG$380.00$312.8921.45%40.06%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Jan 26, 2026Cowen & Co.BuyHolddowngrade
Jan 12, 2026BarclaysEqual-WeightUnderweightdowngrade
Jan 09, 2026BernsteinOutperformOutperformhold
Jan 09, 2026Goldman SachsBuyBuyhold
Dec 18, 2025UBSBuyBuyhold
Dec 16, 2025Evercore ISIOutperforminitialise
Dec 04, 2025Cowen & Co.BuyBuyhold
Nov 24, 2025Canaccord GenuityBuyBuyhold
Nov 21, 2025RBC CapitalOutperformOutperformhold
Nov 19, 2025UBSBuyBuyupgrade

Financial Forecast

EPS Forecast

$0 $1 $2 $3 $4 $5 $6 $7 $8 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$0.25$0.07$2.96$5.97----
Avg Forecast$0.13$0.42$1.99$3.21$3.93$4.95$5.96$7.30
High Forecast$0.13$0.43$2.08$3.36$4.30$5.68$6.79$7.55
Low Forecast$0.13$0.41$1.86$3.11$3.71$3.58$4.76$7.08
Surprise %92.31%-83.33%48.74%85.98%----

Revenue Forecast

$1B $2B $2B $3B $3B $4B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$1.10B$1.31B$1.70B$2.07B----
Avg Forecast$1.09B$1.27B$1.65B$2.06B$2.43B$2.86B$3.32B$3.75B
High Forecast$1.11B$1.30B$1.69B$2.11B$2.49B$2.86B$3.35B$3.85B
Low Forecast$1.07B$1.24B$1.64B$2.05B$2.40B$2.85B$3.28B$3.67B
Surprise %0.66%2.88%2.96%0.71%----

Net Income Forecast

$-150M $0 $150M $300M $450M $600M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$16.80M$4.60M$206.30M$418.30M----
Avg Forecast$4.65M$-70.49M$206.30M$238.15M$289.34M$368.31M$434.07M$537.52M
High Forecast$17.25M$-30.76M$322.59M$247.32M$316.29M$418.31M$499.77M$555.71M
Low Forecast$-7.94M$-110.23M$90.01M$228.97M$273.53M$263.30M$350.38M$521.49M
Surprise %261.00%-106.53%-75.65%----

PODD Forecast FAQ

Is Insulet stock a buy?

Insulet stock has a consensus rating of Buy, based on 46 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 32 Buy, 11 Hold, 3 Sell, and 0 Strong Sell, reflecting a consensus that Insulet is a favorable investment for most analysts.

What is Insulet's price target?

Insulet's price target, set by 46 Wall Street analysts, averages $378.9 over the next 12 months. The price target range spans from $274 at the low end to $450 at the high end, suggesting a potential 39.66% change from the previous closing price of $271.31.

How does Insulet stock forecast compare to its benchmarks?

Insulet's stock forecast shows a 39.66% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the medical device stocks industry (19.94%).

What is the breakdown of analyst ratings for Insulet over the past three months?

  • January 2026: 19.23% Strong Buy, 73.08% Buy, 7.69% Hold, 0% Sell, 0% Strong Sell.
  • December 2025: 20.00% Strong Buy, 72.00% Buy, 8.00% Hold, 0% Sell, 0% Strong Sell.
  • November 2025: 20.00% Strong Buy, 68.00% Buy, 12.00% Hold, 0% Sell, 0% Strong Sell.

What is Insulet’s EPS forecast?

Insulet's average annual EPS forecast for its fiscal year ending in December 2025 is $3.93, marking a -34.17% decrease from the reported $5.97 in 2024. Estimates for the following years are $4.95 in 2026, $5.96 in 2027, and $7.3 in 2028.

What is Insulet’s revenue forecast?

Insulet's average annual revenue forecast for its fiscal year ending in December 2025 is $2.43B, reflecting a 17.42% increase from the reported $2.07B in 2024. The forecast for 2026 is $2.86B, followed by $3.32B for 2027, and $3.75B for 2028.

What is Insulet’s net income forecast?

Insulet's net income forecast for the fiscal year ending in December 2025 stands at $289.34M, representing a -30.83% decrease from the reported $418.3M in 2024. Projections indicate $368.31M in 2026, $434.07M in 2027, and $537.52M in 2028.